Jaimiess Kit
Product Images NDC 70700-123

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Jaimiess (NDC 70700-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Jaimiess Barchart

This text appears to be a chart or graph showing the percentage of participants experiencing bleeding and/or spotting during various cycles, broken down by specific days and time periods. The chart includes information for cycles 1 through 4 and a total participant number (N) for each cycle.*

FDA Label Image

Jaimiess-blistercard (Jaimiess Blister)

FDA Label Image

Jaimiess-carton (Jaimiess Carton)

FDA Label Image

Jaimiess Effect Estimate

FDA Label Image

Jaimiess Ethinyl Estradiol

FDA Label Image

Jaimiess Flowchart

This text appears to be describing various forms of birth control and their effectiveness rates. It lists methods such as implants, injections, intrauterine devices, and sterilization as having a low rate of pregnancy (fewer than 1 per 100 women per year), while techniques like birth control pills, skin patches, and vaginal rings have a moderate rate (10-20 pregnancies per 100 women per year). The text also mentions methods like condoms, diaphragms, spermicide, and withdrawal, which have a higher rate of pregnancy. Finally, it lists the option of not using any birth control.*

FDA Label Image

Jaimiess Levonorgestrel

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.